Trial · NCT01072877
Adverse events60
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 60
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Vehicle | 5 | 56 | 5 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Polidocanol Injectable Foam 0.125% | 11 | 57 | 11 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Polidcanol Injectable Foam 0.5% | 10 | 51 | 10 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Polidocanol Injectable Foam 1.0% | 10 | 52 | 10 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Polidocanol Endovenous Microfoam 2.0% | 6 | 63 | 6 |
| other | Thrombophlebitis superficial | Vascular disorders | Vehicle | 1 | 56 | 1 |
| other | Thrombophlebitis superficial | Vascular disorders | Polidocanol Injectable Foam 0.125% | 7 | 57 | 7 |
| other | Thrombophlebitis superficial | Vascular disorders | Polidcanol Injectable Foam 0.5% | 5 | 51 | 5 |
| other | Thrombophlebitis superficial | Vascular disorders | Polidocanol Injectable Foam 1.0% | 4 | 52 | 4 |
| other | Thrombophlebitis superficial | Vascular disorders | Polidocanol Endovenous Microfoam 2.0% | 8 | 63 | 8 |
| other | Injection site hematoma | Vascular disorders | Vehicle | 1 | 56 | 1 |
| other | Injection site hematoma | Vascular disorders | Polidocanol Injectable Foam 0.125% | 3 | 57 | 3 |
| other | Injection site hematoma | Vascular disorders | Polidcanol Injectable Foam 0.5% | 8 | 51 | 8 |
| other | Injection site hematoma | Vascular disorders | Polidocanol Injectable Foam 1.0% | 4 | 52 | 4 |
| other | Injection site hematoma | Vascular disorders | Polidocanol Endovenous Microfoam 2.0% | 3 | 63 | 3 |
| other | Limb discomfort | Musculoskeletal and connective tissue disorders | Vehicle | 2 | 56 | 2 |
| other | Limb discomfort | Musculoskeletal and connective tissue disorders | Polidocanol Injectable Foam 0.125% | 2 | 57 | 2 |
| other | Limb discomfort | Musculoskeletal and connective tissue disorders | Polidcanol Injectable Foam 0.5% | 3 | 51 | 3 |
| other | Limb discomfort | Musculoskeletal and connective tissue disorders | Polidocanol Injectable Foam 1.0% | 3 | 52 | 3 |
| other | Limb discomfort | Musculoskeletal and connective tissue disorders | Polidocanol Endovenous Microfoam 2.0% | 6 | 63 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01072877/events